Basic Research Open Access
Copyright ©The Author(s) 2003. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jan 15, 2003; 9(1): 134-136
Published online Jan 15, 2003. doi: 10.3748/wjg.v9.i1.134
Effects of tetrandrine on calcium and potassium currents in isolated rat hepatocytes
Hong-Yi Zhou, Fang Wang, Lan Cheng, Li-Ying Fu, Ji Zhou, Wei-Xing Yao, Department of Pharmmacology, Tongji medical college of Huazhong university of science and technology, Wuhan 430030, Hubei Province, China
Author contributions: All authors contributed equally to the work.
Correspondence to: Hong-Yi Zhou, Department of Pharmmacology, Tongji medical college of Huazhong university of science and technology, 13 hangkong Road, Wuhan 430030, Hubei Province, China. zhouhy518@yahoo.com.cn
Telephone: +86-27-83644206
Received: June 27, 2002
Revised: July 10, 2002
Accepted: July 25, 2002
Published online: January 15, 2003

Abstract

AIM: To study the effects of tetrandrine (Tet) on calcium release-activated calcium current (ICRAC), delayed rectifier potassium current (IK), and inward rectifier potassium currents (IK1) in isolated rat hepatocytes.

METHODS: Hepatocytes of rat were isolated by using perfusion method. Whole cell patch-clamp techniques were used in our experiment.

RESULTS: The peak amplitude of ICRAC was -508 ± 115 pA (n = 15), its reversal potential of ICRAC was about 0 mV. At the potential of -100 mV, Tet inhibited the peak amplitude of ICRAC from -521 ± 95 pA to -338 ± 85 pA (P < 0.01 vs control, n = 5), with the inhibitory rate of 35% at 10 µmol/L and from -504 ± 87 pA to -247 ± 82 pA (P < 0.01 vs control, n = 5), with the inhibitory rate of 49% at 100 µmol/L, without affecting its reversal potential. The amplitude of ICRAC was dependent on extracellular Ca2+ concentration. The peak amplitude of ICRAC was -205 ± 105 pA (n = 3) in tyrode’s solution with Ca2+ 1.8 mmol/L (P < 0.01 vs the peak amplitude of ICRAC in external solution with Ca2+ 10 mmol/L). Tet at the concentration of 10 and 100 µmol/L did not markedly change the peak amplitude of delayed rectifier potassium current and inward rectifier potassium current (P > 0.05 vs control).

CONCLUSION: Tet protects hepatocytes by inhibiting ICRAC, which is not related to IK and IK1.




INTRODUCTION

Tetrandrine (Tet) is a bisbenzylisoquinoline alkaloid from a Chinese medicinal herb (stephania tetrandra S. Moore). In the past decade, lots of studies demonstrated that Tet possessed multiple bioactivities, such as potential immunomodulating, anticarcinoma[1] and protective effect on CCl4-injured hepatocytes[2]. It has also been used in the treatment of ischemic heart diseases[3] and hypertension[3,4]. Recently, the antifibrotic effects of Tet have been received considerable attention[1,5-10]. The former researches of Tet on the liver have probed into cellular and molecular levels[9,10]. In the present paper, we used whole-cell patch-clamp technique to observe the effects of Tet on ICRAC, IK, IK1 in normal isolated rat hepatocytes, in order to have a better understanding its hepatoprotective and antifibrotic effects.

MATERIALS AND METHODS
Solutions and drugs

Tet was from Jinhua Pharmaceutical Co. The stock solution (10 mmol/L) was dissolved in distilled water after acidification with 0.1 mol/L HCl and neutralized with 0.1 mol/L NaOH. Ca2+-free Hank’s solution was prepared without Ca2+ and Mg2+. KB solution contained (mmol/L): glutamic acid 70, taurine 15, KCl 130, KH2PO4 10, HEPES 10, glucose 11, egtazic acid 0.5, pHwas adjusted to 7.4 with KOH. The external solution used to record Icrac contained (mmol/L): NaCl 140, KCl 2.8, CaCl2 10, MgCl2 0.5, glucose 11, HEPES 10, pHwas adjusted to 7.4 with NaOH. The internal solution used to record ICRAC contained (mmol/L): potassium-glutamate 145, NaCl 8, MgCl2 1, Mg-ATP 0.5, egtazic acid 10, HEPES 10, pHwas adjusted to 7.2 with KOH. The external solution used to record IK contained (mmol/L): NaCl 144, KCl 4, CaCl2 1.8, MgCl2 0.53, NaH2PO4 0.33, glucose 5.5, HEPES 5, pHwas adjusted to 7.4 with NaOH. The internal solution used to record IK contained (mmol/L): KCl 130, K2ATP 5, creatine phosphate 5, HEPES 5, pHwas adjusted to 7.2 with KOH. The same external and internal solutions used to record IK1 contained(mmol/L): KCl 7, MgCl2 2, egtazic acid 1, potassium-glutamate 130, HEPES 10, pHwas adjusted to 7.4 with KOH.

Isolation of single hepatocytes

Hepatocytes were isolated with the modified method reported by Seglen[11]. Briefly, adult wistar rats of either sex (175 ± 25 g) were anesthetized by intraperitoneal injection of pentobarbital sodium (50 mg/kg). The portal vein was cannulated and perfused with oxygenated Ca2+-free Hank’s solution 30 ml/min at 37 °C for 4-5 min followed by perfusion with Ca2+-free Hank’s solution containing collagenase (Type 1, Sigma) (0.3 g/L) for 10 min. The liver was chopped in 10 ml Ca2+-free Hank’s solution. The cell suspension was filtered through 200 mesh gauze and then centrifuged three times (50 g, 2 min) to separate liver cells. Cells were plated onto the coverslips and incubated in KB medium for 2 hour and preserved in DMEM at 4 °C.

Electrophysiologic recording

Whole-cell recordings were performed using an PC-II patch clamp amplifier (Huazhong university of science and technology). The recording chamber (1.5 ml) was perfused with the corresponding external solution. The pipettes were pulled in two stages from hard glass capillaries using a vertical microelectrode puller (Narishige, Japan). Electrode has a resistance of 2-5 MΩ for whole-cell recording when filled with electrode internal solution. All experiments were conducted at 22 ± 2 °C.

Statistic analysis

The data were expressed as -χ±s. Statistical significances were analyzed by a unpaired t-test. A value of P < 0.05 was considered significant.

RESULTS
Effect of Tet on calcium release-activated calcium current (ICRAC)

ICRAC was elicited for 200 ms from the holding potential of 0 mV to various potentials ranging from -10 mV to +80 mV with the step of 20 mV every 5 s[12]. The peak amplitude of ICRAC was -508 ± 115 pA (n = 15) and the reversal potential of ICRAC was about 0 mV, the current was steady and without run-down in 5 mins. Tet inhibited the peak amplitude of ICRAC from -521 ± 95 pA to -338 ± 85 pA (P < 0.01 vs control, n = 5), with the inhibitory rate of 35% at 10 µmol/L and from -504 ± 87 pA to -247 ± 82 pA (P < 0.01 vs control, n = 5), with the inhibitory rate of 49% at 100 µmol/L. Tet did not affect the shape of its current voltage curve (Figure 1, Figure 2).

Figure 1
Figure 1 Effect of Tet on ICRAC in isolated rat hepatocytes. ICRAC traces before and after Tet 10 µmol/L and 100 µmol/L. ICRAC was elicited for 200 ms from the holding potential of 0 mV to various potentials ranging from -100 mV to +80 mV with step of 20 mV.
Figure 2
Figure 2 Effect of Tet on I-V relationship of ICRAC in isolated rat hepatocytes. Especially at the potential of -100 mV, Tet inhibited the peak amplitude of ICRAC with the inhibitory rate of 35% at 10 µmol/L and with the inhibitory rate of 49% at 100 µmol/L. ● control; ○ 10 µmol/L; ▼ 100 µmol/L.

The amplitude of ICRAC was dependent on extracellular Ca2+ concentration. The peak amplitude of ICRAC was -205 ± 105 pA (n = 3) in tyrode’s solution with Ca2+ 1.8 mmol/L (P < 0.01 vs the peak amplitude of ICRAC in external solution with Ca2+ 10 mmol/L). Tet at 10 µmol/L decreased ICRAC from -205 ± 105 pA to -148 ± 96 pA (n = 3).

Effect of Tet on delayed rectifier potassium current(IK)

IK was elicited by 900 ms depolarization steps from +30 mV to +140 mV with step of 10 mV at holding potential of -50 mV[13]. Tet at 10 and 100 µmol/L did not change the peak amplitude of IK [from 2014 ± 686pA to 2030 ± 692pA and 2047 ± 710pA respectively, n = 5, cells from 3 rats, P > 0.05]. Tet did not affect the shape of its current voltage curve.

Effect of Tet on inward rectifier potassium current(IK1)

IK1 was elicited by a number of step pulses (40 ms) from the holding potential (Eh) of 0 mV to test potentials from -200 mV to +175 mV with the step of 10 mV[14]. Tet at 10 and 100 µmol/L did not change the peak amplitude of IK1 [from 2254 ± 718pA to 2239 ± 700pA and 2224 ± 658pA respectively, n = 5, cells from 3 rats, P > 0.05]. Tet did not affect the shape of its current voltage curve.

DISCUSSION

Hepatic fibrosis is a common consequence of chornic liver injury from many causes[15-19], and the sustained hepatic injury is a primary factor for hepatic fibrogenesis[20-28]. Preventing hepatocyte from injury is a matter of primary importance in blocking the fibrogenic pathway. Tet has been considered as an effective antifibrotic and hepatoprotective agent[1,2,5-10], but its protection against toxic cell death has never been well illustrated.

The Ca2+ influx is mainly mediated by voltage-operated Ca2+ channels and receptor-activated Ca2+ channels. Voltage-operated Ca2+ channels are not present in hepatocytes[29]. Calcium influx in isolated hepatocytes mainly depend on receptor-mediated Ca2+ entry which has been identified by indirect methods[30]. Previous studies have shown that one type of receptor-activated Ca2+ channels, most likely a store-operated Ca2+ channel, in freshly isolated rat hepatocytes is inhibited by high concentrations of L-type voltage-operated Ca2+ channels antagonists[30,31]. Besides, the mRNA encoding isoforms of L-type voltage-operated Ca2+ channels has been detected in rat hepatocytes, these observation suggested that receptor-activated Ca2+ channels in rat hepatocytes exhibit some characteristics of voltage-operated Ca2+ channels[32]. Cui et al[12] reported that ICRAC (an important sub-type of store-operated Ca2+ channels) existed in isolated rat hepatocytes and 50 µmol/L of verapamil, diltiazem and nifedipine could decrease the amplitude of ICRAC effectively. The results in our experiment showed that Tet at the concentration of 10 and 100 µmol/L could decrease the peak amplitude of I CRAC. The concentration that Tet made a half-maximal inhibition of ICRAC was approximately 100 µmol/L, which was substantially higher than that needed for the half-maximal inhibition of L-type voltage-operated Ca2+ channels by Tet. It suggested that Tet could protect hepatocytes by inhibiting ICRAC and decreasing intracellular Ca2+ concentration, in which a higher concentration of Tet was needed.

Nietsch’s study demonstrated that the activation of potassium and chloride channels by TNF-α induced apoptosis and death of the HTC rat hepatoma cells, which could be significantly delayed by K+ channel blockers (Ba2+ and quinine)[33]. Our result showed that Tet had no effect on IK and IK1, which suggested that the hepatoprotection of Tet might not relate to potassium channels. However, whether calcium activated potassium channels exist in rat hepatocytes or not remains controversial[34,35]. The effect of Tet on potassium channels requires further investigation.

In conclusion, Tet protects hepatocytes by inhibiting ICRAC, which is not related to I K and IK1.

Footnotes

Edited by Zhu L

References
1.  Li DG, Wang ZR, Lu HM. Pharmacology of tetrandrine and its therapeutic use in digestive diseases. World J Gastroenterol. 2001;7:627-629.  [PubMed]  [DOI]  [Cited in This Article: ]
2.  Chen XH, Hu YM, Liao YQ. Protective effects of tetrandrine on CCl4-injured hepatocytes. Zhongguo Yaoli Xuebao. 1996;17:348-350.  [PubMed]  [DOI]  [Cited in This Article: ]
3.  Wong TM, Wu S, Yu XC, Li HY. Cardiovascular actions of Radix Stephaniae Tetrandrae: a comparison with its main component, tetrandrine. Acta Pharmacol Sin. 2000;21:1083-1088.  [PubMed]  [DOI]  [Cited in This Article: ]
4.  Cheng D, Chen W, Mo X. Acute effect of tetrandrine pulmonary targeting microspheres on hypoxic pulmonary hypertension in rats. Chin Med J (Engl). 2002;115:81-83.  [PubMed]  [DOI]  [Cited in This Article: ]
5.  Lee SH, Nan JX, Sohn DH. Tetrandrine prevents tissue inhibitor of metalloproteinase-1 messenger RNA expression in rat liver fibrosis. Pharmacol Toxicol. 2001;89:214-216.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 10]  [Cited by in F6Publishing: 12]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
6.  Liu D, Li G, Liu D, Cao Y. [Effects of tetrandrine on the synthesis of collagen and scar-derived fibroblast DNA]. Zhonghua Shao Shang Za Zhi. 2001;17:222-224.  [PubMed]  [DOI]  [Cited in This Article: ]
7.  Park PH, Nan JX, Park EJ, Kang HC, Kim JY, Ko G, Sohn DH. Effect of tetrandrine on experimental hepatic fibrosis induced by bile duct ligation and scission in rats. Pharmacol Toxicol. 2000;87:261-268.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 36]  [Cited by in F6Publishing: 40]  [Article Influence: 1.7]  [Reference Citation Analysis (0)]
8.  Ma JY, Barger MW, Hubbs AF, Castranova V, Weber SL, Ma JK. Use of tetrandrine to differentiate between mechanisms involved in silica-versus bleomycin-induced fibrosis. J Toxicol Environ Health A. 1999;57:247-266.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 18]  [Cited by in F6Publishing: 12]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
9.  Li DG, Lu HM, Chen YW. Progression on antifibrotic effects of tetrandrine. Shijie Huaren Xiaohua Zazhi. 1999;7:171-172.  [PubMed]  [DOI]  [Cited in This Article: ]
10.  Li DG, Lu HM, Chen YW. Progress in studies of tetrandrine against hepatofibrosis. World J Gastroenterol. 1998;4:377-379.  [PubMed]  [DOI]  [Cited in This Article: ]
11.  Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol. 1976;13:29-83.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 3785]  [Cited by in F6Publishing: 3859]  [Article Influence: 80.4]  [Reference Citation Analysis (0)]
12.  Cui GY, Li JM, Cui H, Hao LY, Liu DJ, Zhang KY. Effects of calcium channel blockers on calcium release-activated calcium currents in rat hepatocytes. Zhongguo Yaoli Xuebao. 1999;20:415-418.  [PubMed]  [DOI]  [Cited in This Article: ]
13.  Li JM, Cui GY, Liu DJ, Cui H, Chang TH, Wang YP, Zhang KY. Effects of N-methyl berbamine on delayed outward potassium current in isolated rat hepatocytes. Zhongguo Yaoli Xuebao. 1998;19:24-26.  [PubMed]  [DOI]  [Cited in This Article: ]
14.  Henderson RM, Graf J, Boyer JL. Inward-rectifying potassium channels in rat hepatocytes. Am J Physiol. 1989;256:G1028-G1035.  [PubMed]  [DOI]  [Cited in This Article: ]
15.  Wu CH. Fibrodynamics-elucidation of the mechanisms and sites of liver fibrogenesis. World J Gastroenterol. 1999;5:388-390.  [PubMed]  [DOI]  [Cited in This Article: ]
16.  Albanis E, Friedman SL. Hepatic fibrosis. Pathogenesis and principles of therapy. Clin Liver Dis. 2001;5:315-334, v-vi.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 145]  [Cited by in F6Publishing: 156]  [Article Influence: 6.8]  [Reference Citation Analysis (0)]
17.  Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem. 2000;275:2247-2250.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 1567]  [Cited by in F6Publishing: 1573]  [Article Influence: 65.5]  [Reference Citation Analysis (0)]
18.  Brenner DA, Waterboer T, Choi SK, Lindquist JN, Stefanovic B, Burchardt E, Yamauchi M, Gillan A, Rippe RA. New aspects of hepatic fibrosis. J Hepatol. 2000;32:32-38.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 138]  [Cited by in F6Publishing: 148]  [Article Influence: 6.2]  [Reference Citation Analysis (0)]
19.  Maddrey WC. Alcohol-induced liver disease. Clin Liver Dis. 2000;4:115-131, vii.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 52]  [Cited by in F6Publishing: 53]  [Article Influence: 2.2]  [Reference Citation Analysis (0)]
20.  Liu Y, Shimizu I, Omoya T, Ito S, Gu XS, Zuo J. Protective effect of estradiol on hepatocytic oxidative damage. World J Gastroenterol. 2002;8:363-366.  [PubMed]  [DOI]  [Cited in This Article: ]
21.  Wei HS, Li DG, Lu HM, Zhan YT, Wang ZR, Huang X, Zhang J, Cheng JL, Xu QF. Effects of AT1 receptor antagonist, losartan, on rat hepatic fibrosis induced by CCl(4). World J Gastroenterol. 2000;6:540-545.  [PubMed]  [DOI]  [Cited in This Article: ]
22.  Hu YY, Liu CH, Wang RP, Liu C, Liu P, Zhu DY. Protective actions of salvianolic acid A on hepatocyte injured by peroxidation in vitro. World J Gastroenterol. 2000;6:402-404.  [PubMed]  [DOI]  [Cited in This Article: ]
23.  Chen PS, Zhai WR, Zhou XM, Zhang JS, Zhang YE, Ling YQ, Gu YH. Effects of hypoxia, hyperoxia on the regulation of expression and activity of matrix metalloproteinase-2 in hepatic stellate cells. World J Gastroenterol. 2001;7:647-651.  [PubMed]  [DOI]  [Cited in This Article: ]
24.  Hamasaki K, Nakashima M, Naito S, Akiyama Y, Ohtsuru A, Hamanaka Y, Hsu CT, Ito M, Sekine I. The sympathetic nervous system promotes carbon tetrachloride-induced liver cirrhosis in rats by suppressing apoptosis and enhancing the growth kinetics of regenerating hepatocytes. J Gastroenterol. 2001;36:111-120.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 10]  [Cited by in F6Publishing: 12]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
25.  Hu Y, Wang R, Zhang X, Liu C, Liu C, Liu P, Zhu D. Effects of carbon tetrachloride-injured hepatocytes on hepatic stellate cell activation and salvianolic acid A preventive action in vitro. Zhonghua Ganzangbing Zazhi. 2000;8:299-301.  [PubMed]  [DOI]  [Cited in This Article: ]
26.  Kim KY, Choi I, Kim SS. Progression of hepatic stellate cell activation is associated with the level of oxidative stress rather than cytokines during CCl4-induced fibrogenesis. Mol Cells. 2000;10:289-300.  [PubMed]  [DOI]  [Cited in This Article: ]
27.  Shi J, Aisaki K, Ikawa Y, Wake K. Evidence of hepatocyte apoptosis in rat liver after the administration of carbon tetrachloride. Am J Pathol. 1998;153:515-525.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 188]  [Cited by in F6Publishing: 189]  [Article Influence: 7.3]  [Reference Citation Analysis (0)]
28.  Greenwel P, Domínguez-Rosales JA, Mavi G, Rivas-Estilla AM, Rojkind M. Hydrogen peroxide: a link between acetaldehyde-elicited alpha1(I) collagen gene up-regulation and oxidative stress in mouse hepatic stellate cells. Hepatology. 2000;31:109-116.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 143]  [Cited by in F6Publishing: 153]  [Article Influence: 6.4]  [Reference Citation Analysis (0)]
29.  Sawanobori T, Takanashi H, Hiraoka M, Iida Y, Kamisaka K, Maezawa H. Electrophysiological properties of isolated rat liver cells. J Cell Physiol. 1989;139:580-585.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 22]  [Cited by in F6Publishing: 27]  [Article Influence: 0.8]  [Reference Citation Analysis (0)]
30.  Striggow F, Bohnensack R. Verapamil and diltiazem inhibit receptor-operated calcium channels and intracellular calcium oscillations in rat hepatocytes. FEBS Lett. 1993;318:341-344.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 29]  [Cited by in F6Publishing: 30]  [Article Influence: 1.0]  [Reference Citation Analysis (0)]
31.  Hughes BP, Milton SE, Barritt GJ, Auld AM. Studies with verapamil and nifedipine provide evidence for the presence in the liver cell plasma membrane of two types of Ca2+ inflow transporter which are dissimilar to potential-operated Ca2+ channels. Biochem Pharmacol. 1986;35:3045-3052.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 56]  [Cited by in F6Publishing: 62]  [Article Influence: 1.6]  [Reference Citation Analysis (0)]
32.  Brereton HM, Harland ML, Froscio M, Petronijevic T, Barritt GJ. Novel variants of voltage-operated calcium channel alpha 1-subunit transcripts in a rat liver-derived cell line: deletion in the IVS4 voltage sensing region. Cell Calcium. 1997;22:39-52.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 26]  [Cited by in F6Publishing: 30]  [Article Influence: 1.1]  [Reference Citation Analysis (0)]
33.  Nietsch HH, Roe MW, Fiekers JF, Moore AL, Lidofsky SD. Activation of potassium and chloride channels by tumor necrosis factor alpha. Role in liver cell death. J Biol Chem. 2000;275:20556-20561.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 86]  [Cited by in F6Publishing: 95]  [Article Influence: 4.0]  [Reference Citation Analysis (0)]
34.  Takanashi H, Sawanobori T, Kamisaka K, Maezawa H, Hiraoka M. Ca(2+)-activated K+ channel is present in guinea-pig but lacking in rat hepatocytes. Jpn J Physiol. 1992;42:415-430.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 13]  [Cited by in F6Publishing: 12]  [Article Influence: 0.4]  [Reference Citation Analysis (0)]
35.  Duszynski J, Elensky M, Cheung JY, Tillotson DL, LaNoue KF. Hormone-regulated Ca2+ channel in rat hepatocytes revealed by whole cell patch clamp. Cell Calcium. 1995;18:19-29.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 17]  [Cited by in F6Publishing: 18]  [Article Influence: 0.6]  [Reference Citation Analysis (0)]